Medicines and medical devices

Guidance and services

• Medicines shortages
• National Institute for Health and Care Excellence (NICE) guidelines
• COVID-19 treatments
• Check what help you could get to pay for NHS costs
• Free prescriptions
• Hormone replacement therapy (HRT) medicines
• Attention Deficit Hyperactivity Disorder (ADHD) medicines
• Pancreatic Enzyme Replacement Therapy (PERT) medicines
• Pharmaceutical needs assessment: guidance for local health boards
• Ionising radiation (medical exposure) regulations (WHC/2018/029)
• Diagnosing and treating Lyme disease (WHC/2018/021)
• Ionising radiation: requirements from February 2018 (WHC/2018/007)
• Community pharmacies: clinical governance
• Cannabis based products for medicinal use (WHC/2018/039)
• Antimicrobial resistance (WHC/2018/020)
• Brexit and medicines supply (WHC/2019/005)
• Attaining the WHO targets for eliminating hepatitis B and C (WHC/2017/048)
• Healthcare workers infected with bloodborne viruses (WHC/2017/045)
• NHS (Pharmaceutical Services) (Wales) Regulations 2020: breach and remedial notices
• Safe clinical use of magnetic resonance imaging (MRI) (WHC/2018/001)
• Availability of gluten free foods for the treatment for coeliac disease (WHC/2019/001)
• Administration of intravenous contrast medium for patients with renal impairment (WHC/2018/003)
• Supply and use of adrenaline auto injectors in schools (WHC/2017/046)
• Prescribing of co-proxamol (WHC/2017/026)
• Healthcare associated infection, device usage and antimicrobial usage survey (WHC/2017/005)
• New treatment fund: directions on implementation timescales (WHC/2017/001)
• Respond to application to release a genetically modified enteric fever vaccine
• CT scanning and general x-ray: good practice report (WHC/2016/048)
• Prescribing guidance for pregabalin and gabapentin (WHC/2016/030)
• Prescribing hormone therapy for trans adults (WHC/2016/040)
• Instruments for tonsil and adenoid surgeries (WHC/2016/014)
• Standards on reporting radiological examinations
• Decontamination of medical devices (WHC/2015/050)
• Genetically Modified Organisms: Prokarium Ltd (19/DR/001/W)
• Prescribing antidepressants to children and young people (WHC/2015/048)
• Revised national steroid treatment card (WHC/2021/008)
• Urgent polio catch-up programme for children under 5 years old (WHC/2022/027)
• Genomics delivery plan 2022 to 2025
• Optimising pharmacy services at hospital discharge
• All Wales guidance for prescribing intervals (WHC/2022/025)
• Further extending the use of Blueteq in secondary care (WHC/2022/032)
• Healthcare associated infections and antimicrobial resistance improvement goals 2023 to 2024 (WHC/2023/31)
• Independent and supplementary prescribing in Wales
• Introduction of Snomed CT as an NHS information standard (WHC/2015/53)
• New treatment fund: directions on the exemptions for health boards and trusts (WHC/2024/020)
• Protected learning time: position statement

Policy and background Includes strategy, reports, projects and assessments.

• New Treatment Fund: access to new treatments
  Policy and strategy
• New Treatment Fund prescribing list: annual reports
  Collection
• The Directions to Local Health Boards and NHS Trusts in Wales 2003 and the Managed Introduction of New Medicines into the National Health Service in Wales Directions 2009 (Amendment) (Wales) Directions 2024
  Legislation
• Directions to Local Health Boards and NHS Trusts in Wales 2003 and the Managed Introduction of New Medicines Into the National Health Service in Wales Directions 2009 (Amendment) (Wales) Directions 2017 (2017 No. 17)
  Legislation
• Community pharmacy contractual framework reform
  Policy and strategy
• Genomics for precision medicine strategy
  Policy and strategy
• Genetic and genomic medicine in Wales
  Report
  Welsh Scientific Advisory Committee
• Andrew Evans
  Key people
• Review of dispensing volumes in community pharmacies: Welsh Government response
  Policy and strategy
• Temporary approval of home use for both stages of early medical abortion
  Legislation
• Radiotherapy equipment needs and workforce implications 2006 to 2016
  Report
  Welsh Scientific Advisory Committee
• The Pharmaceutical Services (Advanced Services) (Appliances) (Wales) (Amendment) Directions 2022
  Legislation
• The Pharmaceutical Services (Clinical Services) (Wales) Directions 2022
  Legislation
• Pharmaceutical Services (Clinical Services) (Wales) (Amendment) Directions 2024
  Legislation
• The Abortion Act 1967 – Approval of a Class of Place for Treatment for the Termination of Pregnancy (Wales) 2022
  Legislation
• The Abortion Act 1967 – Revocation of the Approval of a Class of Place for Treatment for the Termination of Pregnancy (Wales) 2022
  Legislation
• The Pharmaceutical Services (Advanced and Enhanced Services) (Wales) (Amendment) Directions 2015
  Legislation
• Directions to Local Health Boards as to the Statement of Financial Entitlements (Amendment) (No. 3) Directions 2017 (2017 No. 30)
  Legislation
• The Pharmaceutical Services (Advanced and Enhanced Services) (Wales) (Amendment) Directions 2014 (2014 No.15)
  Legislation
• The Pharmaceutical Services (Advanced and Enhanced Services) (Wales) (Amendment) Directions 2011 (2011 No.47)
  Legislation
• The Pharmaceutical Services (Advanced Services) (Appliances) (Wales) Directions 2010 (2010 No.13)
  Legislation
• The Managed Introduction of New Medicines into the National Health Service in Wales Directions 2009 (2009 No.9)
  Legislation
• The Pharmaceutical Services (Advanced and Enhanced Services) (Wales) (Amendment) Directions 2008 (2008 No.11)
  Legislation
• The Pharmaceutical Services (Advanced and Enhanced Services) (Wales) Amendment Directions 2006 (2006 No. 88)
  Legislation
• The Primary Medical Services (Influenza and Pneumococcal Immunisation Scheme) (Directed Enhanced Service) Wales) (No. 2) (Amendment) Directions 2023
  Legislation
• Local health boards and NHS Trusts reporting on the introduction of new medicines into the National Health Service in Wales Directions 2023
  Legislation
• Review of clinical pharmacy services at NHS Hospitals in Wales
  Report
• The future of community pharmacy in Wales: one year on
  Report
• Sterile preparation of medicine in NHS Wales (WHC/2024/004)
  Policy and strategy
• Sterile preparation of medicine in NHS Wales
  Policy and strategy
• Policy on single use and reusable laryngoscopes (WHC/2020/015)
  Policy and strategy